On January 22, 2015, the Board of Directors of Emergent BioSolutions Inc. approved an increase in the size of the Board from 9 to 10 directors and appointed Jerome Hauer as a Class III director of the company, with an initial term expiring at the 2015 annual meeting of stockholders.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.47 USD | +5.81% |
|
+8.27% | +210.83% |
03:18pm | Emergent Biosolutions Secures Contracts Worth Over $250 Million From US Health Department | MT |
20/06 | Benchmark Adjusts Emergent Biosolutions Price Target to $8 From $5, Maintains Buy Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+210.83% | 370M | |
+55.96% | 823B | |
+42.31% | 641B | |
-6.98% | 352B | |
+17.21% | 324B | |
+7.53% | 301B | |
+14.02% | 241B | |
+1.64% | 223B | |
+13.66% | 218B | |
+8.21% | 167B |
- Stock Market
- Equities
- EBS Stock
- News Emergent BioSolutions Inc.
- Emergent BioSolutions, Inc. Appoints Jerome Hauer as Class III Director